875 related articles for article (PubMed ID: 18081728)
1. Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass.
Gómez-Ambrosi J; Rodríguez A; Catalán V; Ramírez B; Silva C; Rotellar F; Gil MJ; Salvador J; Frühbeck G
Clin Endocrinol (Oxf); 2008 Aug; 69(2):208-15. PubMed ID: 18081728
[TBL] [Abstract][Full Text] [Related]
2. Increased serum amyloid A concentrations in morbid obesity decrease after gastric bypass.
Gómez-Ambrosi J; Salvador J; Rotellar F; Silva C; Catalán V; Rodríguez A; Jesús Gil M; Frühbeck G
Obes Surg; 2006 Mar; 16(3):262-9. PubMed ID: 16545156
[TBL] [Abstract][Full Text] [Related]
3. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss.
Gumbs AA; Modlin IM; Ballantyne GH
Obes Surg; 2005 Apr; 15(4):462-73. PubMed ID: 15946423
[TBL] [Abstract][Full Text] [Related]
4. Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss.
Kadera BE; Lum K; Grant J; Pryor AD; Portenier DD; DeMaria EJ
Surg Obes Relat Dis; 2009; 5(3):305-9. PubMed ID: 19460674
[TBL] [Abstract][Full Text] [Related]
5. [Serum level of retinol-binding protein 4 in obese patients with insulin resistance and in patients with type 2 diabetes treated with metformin].
Tajtáková M; Semanová Z; Ivancová G; Petrovicová J; Donicová V; Zemberová E
Vnitr Lek; 2007 Sep; 53(9):960-3. PubMed ID: 18019665
[TBL] [Abstract][Full Text] [Related]
6. Visceral adiposity is associated with serum retinol binding protein-4 levels in healthy women.
Lee JW; Im JA; Lee HR; Shim JY; Youn BS; Lee DC
Obesity (Silver Spring); 2007 Sep; 15(9):2225-32. PubMed ID: 17890490
[TBL] [Abstract][Full Text] [Related]
7. [Depot-specific expression of retinol-binding protein 4 in human adipose tissue and their relationship with obesity and insulin resistance].
Lu HY; Li XF; Mu PW; Jiang W; Zeng LY
Zhonghua Yi Xue Za Zhi; 2010 Dec; 90(48):3395-8. PubMed ID: 21223811
[TBL] [Abstract][Full Text] [Related]
8. Factors that influence retinol-binding protein 4-transthyretin interaction are not altered in overweight subjects and overweight subjects with type 2 diabetes mellitus.
Frey SK; Spranger J; Henze A; Pfeiffer AF; Schweigert FJ; Raila J
Metabolism; 2009 Oct; 58(10):1386-92. PubMed ID: 19501859
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance in nondiabetic morbidly obese patients: effect of bariatric surgery.
Pereira JA; Lazarin MA; Pareja JC; de Souza A; Muscelli E
Obes Res; 2003 Dec; 11(12):1495-501. PubMed ID: 14694214
[TBL] [Abstract][Full Text] [Related]
10. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients.
Kopp HP; Kopp CW; Festa A; Krzyzanowska K; Kriwanek S; Minar E; Roka R; Schernthaner G
Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1042-7. PubMed ID: 12714437
[TBL] [Abstract][Full Text] [Related]
11. Differential loss of fat and lean mass in the morbidly obese after bariatric surgery.
Zalesin KC; Franklin BA; Lillystone MA; Shamoun T; Krause KR; Chengelis DL; Mucci SJ; Shaheen KW; McCullough PA
Metab Syndr Relat Disord; 2010 Feb; 8(1):15-20. PubMed ID: 19929598
[TBL] [Abstract][Full Text] [Related]
12. High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans.
Stefan N; Hennige AM; Staiger H; Machann J; Schick F; Schleicher E; Fritsche A; Häring HU
Diabetes Care; 2007 May; 30(5):1173-8. PubMed ID: 17259477
[TBL] [Abstract][Full Text] [Related]
13. Gastric banding for the treatment of type 2 diabetes mellitus in morbidly obese.
Brancatisano A; Wahlroos S; Matthews S; Brancatisano R
Surg Obes Relat Dis; 2008; 4(3):423-9. PubMed ID: 18226973
[TBL] [Abstract][Full Text] [Related]
14. Serum amyloid A: a marker of adiposity-induced low-grade inflammation but not of metabolic status.
Poitou C; Coussieu C; Rouault C; Coupaye M; Cancello R; Bedel JF; Gouillon M; Bouillot JL; Oppert JM; Basdevant A; Clément K
Obesity (Silver Spring); 2006 Feb; 14(2):309-18. PubMed ID: 16571858
[TBL] [Abstract][Full Text] [Related]
15. Pre- and post-prandial plasma ghrelin levels do not correlate with satiety or failure to achieve a successful outcome after Roux-en-Y gastric bypass.
Christou NV; Look D; McLean AP
Obes Surg; 2005 Aug; 15(7):1017-23. PubMed ID: 16105400
[TBL] [Abstract][Full Text] [Related]
16. Effect of significant intermediate-term weight loss on serum leptin levels and body composition in severely obese subjects.
Infanger D; Baldinger R; Branson R; Barbier T; Steffen R; Horber FF
Obes Surg; 2003 Dec; 13(6):879-88. PubMed ID: 14738675
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of weight loss on insulin resistance in surgically treated obese patients.
Muscelli E; Mingrone G; Camastra S; Manco M; Pereira JA; Pareja JC; Ferrannini E
Am J Med; 2005 Jan; 118(1):51-7. PubMed ID: 15639210
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of subclinical hypothyroidism in a morbidly obese population and improvement after weight loss induced by Roux-en-Y gastric bypass.
Moulin de Moraes CM; Mancini MC; de Melo ME; Figueiredo DA; Villares SM; Rascovski A; Zilberstein B; Halpern A
Obes Surg; 2005 Oct; 15(9):1287-91. PubMed ID: 16259889
[TBL] [Abstract][Full Text] [Related]
19. Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus.
Clements RH; Gonzalez QH; Long CI; Wittert G; Laws HL
Am Surg; 2004 Jan; 70(1):1-4; discussion 4-5. PubMed ID: 14964537
[TBL] [Abstract][Full Text] [Related]
20. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study.
Wickremesekera K; Miller G; Naotunne TD; Knowles G; Stubbs RS
Obes Surg; 2005 Apr; 15(4):474-81. PubMed ID: 15946424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
